XTAE
TGTR
Market cap12mUSD
Oct 09, Last price
199.90ILS
1D
5.83%
1Q
-6.55%
Jan 2017
-70.02%
Name
Together Pharma Ltd
Chart & performance
P/E
18.14
P/S
0.32
EPS
0.11
Div yield, %
—
Shrs. gr., 5y
22.34%
Rev. gr., 5y
58.01%
Revenues
110m
+14.13%
Net income
2m
P
CFO
7m
+130.96%
Dividend
Mar 29, 20110.289062 ILS/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Together Pharma Ltd, through its subsidiaries, engages in the cultivation, propagation, import, export, production, storage and distribution of medical cannabis products in Israel. It offers cannabis oils and inflorescences. The company was incorporated in 1991 and is based in Ashkelon, Israel.
Key people
Yoav Elishoov
Head of Pharma division at the Company and at the Group · since 2019
Vice President - Finance · since 2018
Guy Atia
Director · since 2018
Nissim Bracha
Chief Executive Officer, Director · since 2019
Yohanan Danino
Chairman of the Board · since 2019
Nir Sosinsky
Director · since 2018
External Director · since 2019
Adi Bershadsky
External Director · since 2006
Hadar Ron
External Director · since 2019
Independent Director · since 2018
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||